Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, participated in a Globe and Mail panel on stem cells.
Category:
Published on: 9 Dec 2021
Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, is among the experts quoted by The Globe and Mail.
Category:
Published on: 3 Dec 2021
The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel-Giedion Syndrome (SGS). The international team of researchers is coordinated by the Douglas Research Centre and McGill’s Associate Professor and Canada Research Chair in Psychiatric Genetics, Carl Ernst. The EJP RD is a joint program between major funding bodies from over 25 countries, including the CIHR and FRQS.
Category:
Published on: 27 Jan 2021
Providing excellent care and the latest research to help patients
The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.
Category:
Published on: 22 Oct 2018
Industry and academia team up for the benefit of people suffering from ALS
A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.
Category:
Published on: 4 Dec 2017
Microglia, critical to Alzheimer’s research, can now be produced artificially
The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.
Category:
Published on: 16 May 2017
Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.
Category:
Published on: 24 Nov 2016
Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.
Category:
Published on: 2 Apr 2015
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease
Category:
Published on: 26 Mar 2013
